Breaking News, Collaborations & Alliances

Plasticell and CellSpring Form Cell Therapy Collaboration

To validate osteogenic cell therapy and 3D cell culture models for high performance drug screening

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Plasticell, a biotechnology company using combinatorial technologies for stem cell research and optimization of cell and gene therapy manufacturing, is collaborating with CellSpring, a company that has developed a high throughput 3D cell culture system, the 3D Bloom Biopolymer Platform, which enables more informed “stop/go” decisions for preclinical candidates. Plasticell and CellSpring are developing tissue models using 3D Bloom Biopolymer seeded with hMSCs that are subsequently ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters